Tamoxifen withdrawal in women with progressive metastatic breast cancer: a case series of six patients.

Hagio, Kanako; Baba, Motoi; Ishida, Naoko; Oshino, Tomohiro; Kasahara, Risa; Nara, Miyako; Yamashita, Hiroko

Hagio, Kanako; Baba, Motoi; Ishida, Naoko; Oshino, Tomohiro; Kasahara, Risa; Nara, Miyako; Yamashita, Hiroko.

Afiliación

Hagio K; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.
Baba M; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.
Ishida N; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.
Oshino T; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.
Kasahara R; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.
Nara M; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.
Yamashita H; Department of Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648 Japan.

Int Cancer Conf J ; 7(4): 142-147, 2018 Oct.

Article en En | MEDLINE | ID: mdl-31149534

Palabras clave

Endocrine therapy; Metastatic breast cancer; Tamoxifen; Withdrawal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int Cancer Conf J Año: 2018 Tipo del documento: Article